| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10213109 | International Journal of Cardiology | 2018 | 7 Pages |
Abstract
Tocilizumab led to a selective and substantial increase in IP-10 and MIP-1β during the acute phase of NSTEMI, with no or only minor effects on the other measured cytokines. ClinicalTrials.gov, NCT01491074.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ola Kleveland, Thor Ueland, Gabor Kunszt, Marte Bratlie, Arne Yndestad, Kaspar Broch, Espen Holte, Liv Ryan, Brage H. Amundsen, Bjørn Bendz, Svend Aakhus, Terje Espevik, Bente Halvorsen, Tom E. Mollnes, Rune Wiseth, Lars Gullestad, Pål Aukrust,